BIOMAT Database Logo BIOMAT Database Logo

[Danger of the intraperitoneal administration of amphotericin B during continuous ambulatory peritoneal dialysis]. 1984

D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration.
August 1985, Antimicrobial agents and chemotherapy,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Procainamide administration during continuous ambulatory peritoneal dialysis.
December 1985, American heart journal,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
November 1990, Journal of clinical pharmacology,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.
January 1990, Nephron,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
[Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
March 1982, Revista clinica espanola,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
February 1984, Clinical pharmacology and therapeutics,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Pharmacokinetics of ceftriaxone in continuous ambulatory peritoneal dialysis patients after intraperitoneal administration.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients.
January 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis.
March 1995, Journal of the Formosan Medical Association = Taiwan yi zhi,
D Benevent, and N El Akoum, and C Lagarde, and P Brignon, and C Leroux-Robert
Decreased intraperitoneal insulin requirements during peritonitis on continuous ambulatory peritoneal dialysis.
May 1985, British medical journal (Clinical research ed.),
Copied contents to your clipboard!